Em. Mills et al., NERVE GROWTH-FACTOR TREATMENT PREVENTS THE INCREASE IN SUPEROXIDE PRODUCED BY EPIDERMAL GROWTH-FACTOR IN PC12 CELLS, The Journal of biological chemistry, 273(35), 1998, pp. 22165-22168
Stimulation of pheochromocytoma (PC12) cells with the mitogen epiderma
l growth factor (EGF) produced a rapid and robust accumulation of intr
acellular reactive oxygen species (ROS), an accumulation which, in oth
er systems, has been shown to be essential for mitogenesis, Brief pret
reatment of the cells with nerve growth factor (NGF) suppressed the EG
F-mediated ROS increase. EGF failed to produce elevations in ROS in a
PC12 variant stably expressing a dominant-negative p2(ras) construct (
PC12-N17) or in cells pretreated with the MEK inhibitor PD098059, NGF
failed to suppress the increase in ROS in the PC12 variant nnr5, which
lacks p140(trk) receptors, The suppression of the increase in ROS by
NGF was restored in nnr5 cells stably expressing p140(trk) (nnr5-trk),
but NGF failed to prevent the increase in ROS in nnr cells expressing
mutant p140(trk) receptors that lack binding sites for Shc and phosph
olipase C gamma, Among several inhibitors of superoxide-generating enz
ymes, only the lipoxygenase inhibitor, nordihydroguaiaretic acid reduc
ed EGF-mediated ROS accumulation. The inhibitory action of NGF on ROS
production was mimicked by the nitric oxide donor, sodium nitroprussid
e, and was blocked by an inhibitor of nitric-oxide synthetase, L-nitro
arginine methyl ester, These results suggest a novel mechanism for the
rapid interruption of mitogenic signaling by the neurotrophin NGF.